The Effect of Supplementation of Vitamin D3 on Inflammation Induced by 100 km Running, Iron Metabolism and Erythropoiesis

A group of runners received vitamin D (10,000 IU - international unit per day) for two weeks. The aim of the intervention was to check the effect of vitamin D supplementation on selected parameters of inflammation and iron metabolism in comparison with the placebo group. Blood was collected before and after supplementation. Next: before, after 25, 50, 75,100 km running and 12 hours after the run. The data were subjected to statistical analysis.

Study Overview

Detailed Description

Subjects were randomized to two groups: the experimental one, n = 20 and the placebo one, n = 20 with the same age, experience in running and 25(OH)D level. The experimental group received vitamin D3 supplementation (around 10,000 UI/day, i.e., 20 droplets -Vigantol medicament, Merck) and the control group received a placebo (20 droplets of sunflower oil, placed in an identical bottle as vitamin D3) for two weeks before a run. The last vitamin D dose was taken 24 h before the 100 km ultra-marathon. 40 male athletes took part in the 100 km ultra-marathon. Blood was collected before (day 0) and after supplementation (day 14). Next (day 15): before, after 25, 50, 75,100 km running and 12 hours after the run (day 16). The data were subjected to statistical analysis.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • male
  • athletes running ultra-marathons

Exclusion Criteria:

  • vitamin D3 supplementation
  • multivitamin and iron supplementation
  • serum 25(OH)D low < 10 ng/mL
  • serum 25(OH)D high > 100 ng/mL
  • haemoglobin < 10 g/dL
  • other (sports injury, tournament)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Vitamin D
Vigantol 10 000 IU/day (20 droplets) two weeks supplementation (vitamin D3)
cholecalciferol 10000 UI
Other Names:
  • Vitamin D3
Placebo Comparator: Control
sunflower oil, (20 droplets) two weeks supplementation.
sunflower oil

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change in vitamin 25(OH)D level after two-week supplementation.
Time Frame: Day 0 to day 14
Measured parameter: vitamin 25(OH)D [ng/ml].
Day 0 to day 14
The change in parathyroid hormone level after two-week supplementation.
Time Frame: Day 0 to day 14
Measured parameter: parathyroid hormone [pg/ml].
Day 0 to day 14
Observation of changes in inflammatory parameters:interleukin-6 induced by a 100 km run
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
Measured parameter of inflammatory: interleukin-6 [pg/ml]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
Day "15 - the run" and day "16 - 12 hours after the run"
Observation of changes in inflammatory parameters: C reactive protein - CRP induced by 100 km running.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
Measured parameter of inflammatory: CRP[mg/l]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
Day "15 - the run" and day "16 - 12 hours after the run"
Observation of changes in creatine kinase level induced by 100 km running.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
Measured parameter: creatine kinase [U/l]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
Day "15 - the run" and day "16 - 12 hours after the run"
Observation of changes in leucocytes induced by 100 km running.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
Measured parameters of inflammatory: leukocytes [G/l]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
Day "15 - the run" and day "16 - 12 hours after the run"

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Observation of changes in hepcidin level induced by 100 km running.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
Measured parameters of iron metabolism: hepcidin [ng/mL]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
Day "15 - the run" and day "16 - 12 hours after the run"
Observation of changes in serum iron level induced by 100 km running.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
Measured serum iron level [µg/dL].Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
Day "15 - the run" and day "16 - 12 hours after the run"
Observation of changes in ferritin induced by 100 km running.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
Measured parameters of iron metabolism: ferritin [ng/mL]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016).
Day "15 - the run" and day "16 - 12 hours after the run"
Observation of changes in erythrocytes level induced by a 100 km run.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
Measured erythrocytes level [T/l].Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016).
Day "15 - the run" and day "16 - 12 hours after the run"
Observation of changes in reticulocytes induced by a 100 km run.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
Measured reticulocytes [promil]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016).
Day "15 - the run" and day "16 - 12 hours after the run"
Observation of changes in hematocrit induced by a 100 km run.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
Measured hematocrit [%].Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016).
Day "15 - the run" and day "16 - 12 hours after the run"
Observation of changes in erythropoietin level induced by a 100 km run.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
Measured erythropoietin level [mIU - milli-International unit/mL]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016).
Day "15 - the run" and day "16 - 12 hours after the run"
Observation of changes in erythroferrone level induced by a 100 km run.
Time Frame: Day "15 - the run" and day "16 - 12 hours after the run"
Measured erythroferrone level [pg/ml]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016).
Day "15 - the run" and day "16 - 12 hours after the run"

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Katarzyna Kasprowicz, PhD, Gdansk University of Physical Education and Sport

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 19, 2016

Primary Completion (Actual)

November 1, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

December 15, 2022

First Submitted That Met QC Criteria

May 18, 2023

First Posted (Actual)

May 30, 2023

Study Record Updates

Last Update Posted (Actual)

May 30, 2023

Last Update Submitted That Met QC Criteria

May 18, 2023

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Cholecalciferol

3
Subscribe